IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ahmed, I.
Right arrow Articles by Patton, T. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ahmed, I.
Right arrow Articles by Patton, T. F.

Investigative Ophthalmology & Visual Science, Vol 26, 584-587, Copyright © 1985 by Association for Research in Vision and Ophthalmology


ARTICLES AND REPORTS

Importance of the noncorneal absorption route in topical ophthalmic drug delivery

I Ahmed and TF Patton

Transcorneal permeation has traditionally been the mechanism by which topically applied ophthalmic drugs are believed to gain access to the internal ocular structures. Relatively little attention has been given to alternate routes by which drugs may enter the eye. A system has been developed which allowed the investigation in vivo of the contribution of noncorneal absorption to intraocular drug levels after topical dosing. Using timolol and inulin as probe drugs, it was shown that the noncorneal absorption route may contribute significantly to drug penetration into intraocular tissues. Furthermore, results demonstrated that drugs absorbed by the noncorneal route appeared to enter certain intraocular tissues by a mechanism which bypasses the anterior chamber. These studies suggested that intraocular penetration via noncorneal routes involves penetration of drug across the conjunctiva/sclera. Neither reentry from the general circulation after drug absorption into the blood or drug delivery by the local vasculature accounted for the observed results. In terms of topical ophthalmic drug delivery, the noncorneal absorption route may be important for drugs that are poorly absorbed across the cornea due to their physical-chemical properties. We have demonstrated this using inulin as a model for a poorly absorbed, high molecular weight substance.


This article has been cited by other articles:


Home page
IOVSHome page
G. Hollo, J. T. Whitson, R. Faulkner, B. McCue, M. Curtis, H. Wieland, J. Chastain, M. Sanders, L. DeSantis, J. Przydryga, et al.
Concentrations of Betaxolol in Ocular Tissues of Patients with Glaucoma and Normal Monkeys after 1 Month of Topical Ocular Administration
Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 235 - 240.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
L. P. J. Cruysberg, R. M. M. A. Nuijts, D. H. Geroski, J. A. Gilbert, F. Hendrikse, and H. F. Edelhauser
The Influence of Intraocular Pressure on the Transscleral Diffusion of High-Molecular-Weight Compounds
Invest. Ophthalmol. Vis. Sci., October 1, 2005; 46(10): 3790 - 3794.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
H M Brereton, S D Taylor, A Farrall, D Hocking, M A Thiel, M Tea, D J Coster, and K A Williams
Influence of format on in vitro penetration of antibody fragments through porcine cornea
Br. J. Ophthalmol., September 1, 2005; 89(9): 1205 - 1209.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
K. Okabe, H. Kimura, J. Okabe, A. Kato, N. Kunou, and Y. Ogura
Intraocular Tissue Distribution of Betamethasone after Intrascleral Administration Using a Non-biodegradable Sustained Drug Delivery Device
Invest. Ophthalmol. Vis. Sci., June 1, 2003; 44(6): 2702 - 2707.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
J. Okabe, H. Kimura, N. Kunou, K. Okabe, A. Kato, and Y. Ogura
Biodegradable Intrascleral Implant for Sustained Intraocular Delivery of Betamethasone Phosphate
Invest. Ophthalmol. Vis. Sci., February 1, 2003; 44(2): 740 - 744.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. B. Koevary, J. Nussey, and S. Lake
Accumulation of Topically Applied Porcine Insulin in the Retina and Optic Nerve in Normal and Diabetic Rats
Invest. Ophthalmol. Vis. Sci., March 1, 2002; 43(3): 797 - 804.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
E. Toropainen, V.-P. Ranta, A. Talvitie, P. Suhonen, and A. Urtti
Culture Model of Human Corneal Epithelium for Prediction of Ocular Drug Absorption
Invest. Ophthalmol. Vis. Sci., November 1, 2001; 42(12): 2942 - 2948.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
D. H. Geroski and H. F. Edelhauser
Drug Delivery for Posterior Segment Eye Disease
Invest. Ophthalmol. Vis. Sci., April 1, 2000; 41(5): 961 - 964.
[Full Text]


Home page
IOVSHome page
J. Ambati, C. S. Canakis, J. W. Miller, E. S. Gragoudas, A. Edwards, D. J. Weissgold, I. Kim, F. C. Delori, and A. P. Adamis
Diffusion of High Molecular Weight Compounds through Sclera
Invest. Ophthalmol. Vis. Sci., April 1, 2000; 41(5): 1181 - 1185.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1985 by the Association for Research in Vision and Ophthalmology